Clinical Trial Update: Study in Plerixafor and Granulocyte-colony Stimulating Factor Patients With Relapse Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

Phase 1 study of Plerixafor plus Granulocyte-colony Stimulating Factor in relapsed Acute Myeloid Leukemia was terminated. The trial status is TERMINATED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Filgrastim (filgrastim)
• Plerixafor (Plerixafor)

Snippet

Sponsor: French Innovative Leukemia Organisation | Conditions: Acute Myeloid Leukemia | Phase 1 | Status: TERMINATED